Michelle LaSpaluto

Directeur Financier/CFO chez CHIMERIX, INC.

Fortune : 98 900 $ au 30/04/2024

50 ans

Health Technology

Consumer Services

Postes actifs de Michelle LaSpaluto

Sociétés	Poste	Début	Fin
CHIMERIX, INC.	Directeur Financier/CFO	01/12/2023	-
	Investor Relations Contact	01/01/2019	01/12/2023
	Public Communications Contact	-	01/12/2023

Sociétés	Poste	Début	Fin
AlphaVax, Inc. AlphaVax, Inc. Pharmaceuticals: MajorHealth Technology AlphaVax, Inc. involves in clinical-stage biopharmaceutical company. It develops vaccine technology bio products. The firm products include Alphavax and pipleline bio products. It focuses on commercial potential of its alphavaccine vector technology in cancer immunotherapy. The company was founded in 1997 and is headquartered in Durham, NC.	Comptroller/Controller/Auditor	01/05/2000	01/06/2011

East Carolina University	Masters Business Admin
Michigan State University	Undergraduate Degree

Internationale

Etats-Unis

Opérationnelle

Director of Finance/CFO	1
Investor Relations Contact	1
Public Communications Contact	1

Sectorielle

Health Technology	3
Consumer Services	3

Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Sociétés cotées	1
CHIMERIX, INC.	Health Technology

Entreprise privées	1
AlphaVax, Inc. AlphaVax, Inc. Pharmaceuticals: MajorHealth Technology AlphaVax, Inc. involves in clinical-stage biopharmaceutical company. It develops vaccine technology bio products. The firm products include Alphavax and pipleline bio products. It focuses on commercial potential of its alphavaccine vector technology in cancer immunotherapy. The company was founded in 1997 and is headquartered in Durham, NC.	Health Technology

Entreprise privées

Health Technology